Company Filing History:
3 out of 4 
2 out of 76 
1 out of 84 
Years Active: 2017-2024
Title: Innovations in Cancer Treatment by Inventor Dong Hoon Jin
Introduction
Dong Hoon Jin is a prominent inventor based in Seoul, South Korea, known for his significant contributions to the field of molecular biology and cancer treatment. With a remarkable portfolio comprising five patents, Jin has been at the forefront of innovation, particularly in the development of biomarkers that assist in predicting responses to targeted cancer therapies.
Latest Patents
Among his latest patents, two stand out due to their potential impact on cancer treatment. The first patent addresses a biomarker for predicting sensitivity to a protein kinase inhibitor, providing a composition and kit that improves the ability to forecast patient responses to this therapeutic approach. This innovative marker is poised to play a critical role in personalized cancer treatment, enhancing the efficacy of therapies tailored to individual patient needs.
The second patent focuses on a combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET). This method specifically aims to predict susceptibility to MET inhibitors in stomach and lung cancer patients. With its ability to forecast responses effectively, this innovation may be invaluable in advancing treatment methodologies for these particular cancers.
Career Highlights
Throughout his career, Dong Hoon Jin has gained experience by collaborating with renowned organizations, including Wellmarker Bio Co., Ltd. and The Asan Foundation. His work has centered on creating solutions that marry scientific research with practical applications in oncology, enabling more effective interventions for patients.
Collaborations
Dong Hoon Jin has worked alongside notable colleagues such as Seung Woo Hong and Jai Hee Moon. Their joint efforts have fostered an environment of innovation, leading to groundbreaking advances in understanding and treating cancer, underscoring the importance of teamwork in scientific research.
Conclusion
Inventor Dong Hoon Jin’s dedication and innovative spirit have made significant strides in cancer research and treatment. His patented technologies are not only advancing the field but are poised to improve outcomes for cancer patients worldwide. As he continues to work with various institutions and colleagues, the potential for future innovations remains bright, affirming his status as a leading figure in the realm of biomedical inventions.